Zobrazeno 1 - 10
of 300
pro vyhledávání: '"Margitta, Retz"'
Autor:
Christa Babst, Thomas Amiel, Tobias Maurer, Sophie Knipper, Lukas Lunger, Robert Tauber, Margitta Retz, Kathleen Herkommer, Matthias Eiber, Gunhild von Amsberg, Markus Graefen, Juergen Gschwend, Thomas Steuber, Matthias Heck
Publikováno v:
Asian Journal of Urology, Vol 9, Iss 1, Pp 69-74 (2022)
Objective: Cytoreductive radical prostatectomy (cRP) has been proposed as local treatment option in metastatic hormone-sensitive prostate cancer (mHSPC) to prevent local complications and potentially improve oncological outcomes. In this study, we ex
Externí odkaz:
https://doaj.org/article/977dfb82a9bf40beb8784c23aa58c102
Autor:
Jun Li, Stefanie Zschäbitz, Daniel P Petrylak, Margitta Retz, Prabhu Bhagavatheeswaran, Marc-Oliver Grimm, Jose Perez-Gracia, Gwenaelle Gravis, Karim Fizazi, Jeffrey C Goh, Mauricio Burotto, Daniel Castellano, Fred Saad, Andrew J Armstrong, HAKIM MAHAMMEDI, Russell K Pachynski, Louis Lacombe, Diogo Assed Bastos, Steven L McCune, Juan Carlos Vázquez Limón, Edmond M Kwan, Aude Fléchon, David R Shaffer, Neha P Amin, Keziban Ünsal-Kaçmaz, Xuya Wang, Andrea Loehr
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Background CheckMate 9KD (NCT03338790) is a non-randomized, multicohort, phase 2 trial of nivolumab plus other anticancer treatments for metastatic castration-resistant prostate cancer (mCRPC). We report results from cohorts A1 and A2 of CheckMate 9K
Externí odkaz:
https://doaj.org/article/47bed5baf90f4a54860bcc0aa14ca352
Autor:
Sebastian C. Schmid, Florestan J. Koll, Claus Rödel, Philipp Maisch, Andreas Sauter, Franziska Beckert, Anna Seitz, Hubert Kübler, Michael Flentje, Felix Chun, Stephanie E. Combs, Kilian Schiller, Jürgen E. Gschwend, Margitta Retz
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Patients with locally advanced bladder cancer (cT3/4 cN0/N+ cM0) have a poor prognosis despite radical surgical therapy and perioperative chemotherapy. Preliminary data suggest that the combination of radiation and immunotherapy d
Externí odkaz:
https://doaj.org/article/83da227f8a00483e9c4910ad40b9d1ef
Autor:
Urban Emmenegger, Howard Gurney, Emanuela Romano, Neal Shore, Margitta Retz, Christian Poehlein, Charles Schloss, Leonard Appleman, Gwenaelle Gravis, Loïc Mourey, Josep Piulats, Evan Yu, Johann De Bono, William Berry, Peter Fong, Cristiano Ferrario, Tilman Todenhoefer, Henry Conter, Brigitte Laguerre, Xin Tong Li
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/babb2a9e3bb748a0886c1a4672c4279b
Publikováno v:
Journal für Urologie und Urogynäkologie/Österreich. 29:132-138
Autor:
Julia, Wagner, Ricarda, Simon, Jakob Wolf, Büchler, Florian, Kirchhoff, Viktoria, Kehl, Margitta, Retz, Juergen Erich, Gschwend, Andreas, Sauter, Thomas, Horn
Publikováno v:
World Journal of Urology. 41:101-107
Introduction Urothelial bladder cancer (UBC) with clinical suspicion of locally advanced growth or pelvic lymphogenic spread has a high risk of progression and death. Patients and methods Bladder cancer patients with locally advanced (cT3/4) tumor gr
Autor:
Julia Slotta-Huspenina, Kristina Schwamborn, Katja Steiger, Ricarda Simon, Florian Paul Kirchhoff, Jakob Wolf Büchler, Julia Fiedler, Margitta Retz, Roman Nawroth, Christoph Ritschel, Jürgen Erich Gschwend, Thomas Horn
Publikováno v:
Bladder Cancer. 8:269-276
BACKGROUND: Loss of MHC I expression is a tumoral escape mechanism, part of the process of immunoediting. MHC expression patterns and their prognostic and predictive value have not been studied in urothelial carcinoma of the bladder (UC) so far. OBJE
Autor:
Julia Heinzelbecker, Natalie Spieler, Michael Kuehn, Claus Fischer, Björn Volkmer, Friedrich von Rundstedt, Peter Albers, Eduard Becht, Andreas Bannowsky, H. Matthias Weber, Rainer Hofmann, Markus Müller, Sigrun Langbein, Gabriel Steiner, Margitta Retz, Jörn Kamradt, Gudrun Wagenpfeil, Stefan Wellek, Jan Lehmann, Michael Stoeckle
Publikováno v:
Urologic Oncology: Seminars and Original Investigations.
Autor:
Evan Y. Yu, Michael P. Kolinsky, William R. Berry, Margitta Retz, Loic Mourey, Josep M. Piulats, Leonard J. Appleman, Emanuela Romano, Gwenaelle Gravis, Howard Gurney, Martin Bögemann, Urban Emmenegger, Anthony M. Joshua, Mark Linch, Srikala Sridhar, Henry J. Conter, Brigitte Laguerre, Christophe Massard, Xin Tong Li, Charles Schloss, Christian H. Poehlein, Johann S. de Bono
Publikováno v:
European Urology. 82:22-30
Patients with metastatic castration-resistant prostate cancer (mCRPC) frequently receive docetaxel after they develop resistance to abiraterone or enzalutamide and need more efficacious treatments.To evaluate the efficacy and safety of pembrolizumab
Autor:
Roman Nawroth, Jürgen E. Gschwend, Kathleen Herkommer, Mark Thalgott, Tobias Maurer, Hubert Kübler, Michael Autenrieth, Tibor Schuster, Gregor Weirich, Elisabeth Vitzthum, Marc Souchay, Miriam Bandur, Margitta Retz, Matthias M. Heck
Supplemental Table 1: A) Multivariable analysis for the association with biochemical recurrence comparing histopathologic and molecular lymph node status as categorical variables excluding 7 patients receiving adjuvant treatment for pN1-disease B) Mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370b87001874934b8cff9d880a434ee4
https://doi.org/10.1158/1078-0432.22470282
https://doi.org/10.1158/1078-0432.22470282